Trials / Unknown
UnknownNCT01655394
Change of Nerve Conduction Properties in IVIg Dependent Neuropathies
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (estimated)
- Sponsor
- University of Cologne · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
IVIg exert a variety of different immunomodulatory effects and several mechanism of action have been proposed for IVIg. In this study the role of IVIg on short term nerve conduction in patients with immune-mediated neuropathies will be explored.
Detailed description
IVIg exert a variety of different immunomodulatory effects and several mechanism of action have been proposed for IVIg. In this study the role of IVIg on short term nerve conduction in patients with immune-mediated neuropathies will be explored
Conditions
Timeline
- Start date
- 2012-10-01
- Primary completion
- 2014-12-01
- Completion
- 2016-06-01
- First posted
- 2012-08-01
- Last updated
- 2014-12-12
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01655394. Inclusion in this directory is not an endorsement.